Deoxycholic Acid
Who holds supplier records for Deoxycholic Acid? 3 organisations hold a current record for Deoxycholic Acid: an active US FDA Type II Drug Master File or a CEP. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (1), Spain (1) and Italy (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Deoxycholic Acid: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/deoxycholic-acid
Reading the evidence
- 3 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Deoxycholic Acid expires 17 Feb 2032. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (3)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Deoxycholic Acid. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 32305 · latest filing Dec 2017
- CURIA SPAIN SAUSpain Company GMP cert on recordActive DMF 33526 · latest filing Jan 2019
- ICE S.P.A.ItalyCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (1)
Certificates of Suitability on the EDQM register for Deoxycholic Acid, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ICE S.P.A. Reggio Emilia | IT | R1-CEP 2000-335 - Rev 03 Deoxycholic Acid | Mar 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (2 listed products contain Deoxycholic Acid). The latest listed patent expires 17 Feb 2032. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Deoxycholic Acid is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL406393).
Chemical identity
- IUPAC name
- (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
- Canonical SMILES
- C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
- InChIKey
- KXGVEGMKQFWNSR-LLQZFEROSA-N
- Synonyms
- Acide desoxycholique, Acido desoxicolico, ATX-101, ATX-101 (DEOXYCHOLIC ACID), Deoxycholic acid, Desoxycholic acid, DWJ-211, DWJ211, Kybella, NSC-8797, Cholerebic, Choleic acid
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cytolytic Agent
- Physiologic effect
- Decreased Cell Membrane Integrity
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Deoxycholic Acid?
3 organisations hold an active US FDA Type II Drug Master File or a CEP for Deoxycholic Acid: ALIVUS LIFE SCIENCES LTD (India), CURIA SPAIN SAU (Spain) and ICE S.P.A. (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Deoxycholic Acid Drug Master Files are active?
ALIVUS LIFE SCIENCES LTD (DMF 32305) and CURIA SPAIN SAU (DMF 33526). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Deoxycholic Acid have a European Certificate of Suitability?
Yes. 1 organisation holds a valid CEP for Deoxycholic Acid on the EDQM register, including ICE S.P.A. Reggio Emilia (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Deoxycholic Acid?
Yes. The latest patent listed for an approved US product containing Deoxycholic Acid expires 17 Feb 2032, across 2 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Deoxycholic Acid supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Deoxycholic Acid?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.